CLONING AND EXPRESSION OF MCE1A GENE FROM MYCOBACTERIUM TUBERCULOSIS BEIJING AND H37RV STRAIN FOR VACCINE CANDIDATE DEVELOPMENT by Indriarini, Desi et al.
Indriarini et al., Afr., J. Infect. Dis. (2018) 12(S): 127-132 
https://doi.org/10.2101/Ajid.v12i1S.19 
127 
 
CLONING AND EXPRESSION OF MCE1A GENE FROM MYCOBACTERIUM TUBERCULOSIS 
BEIJING AND H37RV STRAIN FOR VACCINE CANDIDATE DEVELOPMENT 
 
Desi Indriarini
1*
, Andriansjah Rukmana
2
, Andi Yasmon
2
 
 
1
Department of Microbiology, Faculty of Medicine, University of Nusa Cendana, Kupang, Indonesia; 
2
Department of Microbiology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia. 
 
*Corresponding Author E-mail: desi.indriarini@gmail.com 
 
 
 
 
 
 
 
 
Abstract 
 
Background: Tuberculosis remains the leading cause of death in the world, especially wherever poverty, malnutrition 
and poor housing prevail. Mycobacterium tuberculosis Beijing strain is the most common strain that causes 
tuberculosis in Indonesia. The wide spread of tuberculosis has been further aggravated by HIV-AIDS and drug 
resistance. Unfortunately, Bacille Calmette-Guerin (BCG) as the current vaccine has different protection function and 
efficacy. According to function analysis,  mce1A gene  was predicted to have a role in host invasion and survival of 
Mycobacterium tuberculosis in human macrophages.  
Materials and Methods: We performed cloning and protein expression of  Mce1A gene of Mycobacterium 
tuberculosis Beijing strain as local isolate and standard strain H37Rv as a comparison on the expression system 
Escherichia coli BL21(DE3). Mce1A gene from the strains were amplified by PCR and inserted into the vector pET28a. 
Each resulting recombinant plasmid was subsequently transformed into E. coli BL21(DE3) and Mce1A protein was 
expressed with IPTG induction.    
Results: E. coli BL21(DE3) was succesfully transformed with a recombinant plasmid that contains the Mce1A gene 
insert with correct orientation and reading frame. There was no mutation found in the amino acids sequence for B and T 
cell epitope. Mce1A expression in E. coli BL21(DE3) showed a protein band that was higher than expected. The 
protein was confirmed with Western blotting using anti-His detector.  
Conclusion: We assumed that Mce1A recombinant protein that has been expressed in E. coli BL21(DE3) is in their 
dimeric form or alternatively formed aggregates of different sizes. 
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Introduction  
 
From past centuries up to the present day, tuberculosis (TB) has remained the leading cause of death in the 
world from infectious disease. It kills about 3 million people and infects almost 9 million others every year wherever 
poverty, malnutrition and poor housing prevail (Goering et al, 2008, Lönnroth et al, 2010). Ninety percent of infected 
individuals are latently infected where they harbor the pathogen in its dormant form, whereas the remaining 10 percent 
suffer from active disease (Kaufmann et al, 2010, Thaiss, 2010). WHO annual report on 2013 estimated that in 2012 
approximately 8.6 million people developed TB  and of those, 1.3 million died from the disease in the world. Indonesia 
is placed at ninth in the world after China, Philipines, Brazil, Russia, Tanzania, Kenya, Thailand and Vietnam in terms 
of number of cases of tuberculosis. In Indonesia, it was estimated for new cases and relapse infection of about 297 
cases per 100,000 people while the mortality rate was about 27 cases per 100,000 people each year (WHO, 2013). 
The wide-spread of TB has been further aggravated by other infectious diseases such as  HIV-AIDS. An 
estimated 1.1 million (13%) of the 8.6 million people who developed TB in 2012 were HIV-positive (WHO, 2013). 
The compromise of immune mechanism in human immunodeficiency virus (HIV)-infected individuals that leads either 
to reactivation of old tuberculous infections or to increased susceptibility to new infection is a major contributor to the 
increasing incidence of tuberculosis (Raviglione et al, 1995). Another factor is  the emergence of multidrug-resistant 
tubercle bacilli (Aziz et al, 2006). Globally in 2012, an estimated ~450,000 people developed MDR-TB and there were 
an estimated 170,000 deaths from MDR-TB (WHO, 2013). Therefore, current antibiotics TB treatment has become 
ineffective.
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Many strains of Mycobacterium tuberculosis caused tuberculosis infection in Indonesia, but the Beijing 
strain is the most common. A study by van Crevel using spoligotyping technique showed that 34 percent of M. 
tuberculosis isolate from Indonesia tuberculosis patients is the Beijing strain. Meanwhile in several countries like 
China, Mongolia, South Korea, Thailand and Vietnam, the percentages for the Beijing strain are about 85, 50, 43, 37 
and 34 respectively. This facts suggests that this clone spreads in Southeast Asia, where TB is endemic (van Crevel et 
al, 2001). Previous studies stated that the Beijing strain is highly prevalent (Anh et al, 2000), more virulent and 
responsible for drug resistance (Kurepina et al, 1998). Beijing genotype strains account for a substantial proportion of 
multidrug resistant TB cases in Azerbaijan, Estonia and Cuba (Marttila et al, 1998, Niemann et al, 1997, Diaz et al, 
1998).
 
Bacille Calmette-Guerin (BCG) is the current vaccine for TB. It has been used for decades to prevent TB on 
uninfected individuals. BCG is impressive with respect to its low cost and its high safety (Ho et al, 2010). It also has 
been used in many countries although its weak protective function varies from 77 percent in United Kingdom to 0 
percent in Chinglepur, India to even negative efficacy in some studies performed in the US (Fine, 1989, Bannon, 1999). 
The difference in protective function of the vaccine perhaps was caused by the difference of the BCG strains that have 
been used (Behr et al, 1999), beside patients co-infection factor by parasites (Malhotra et al, 1999, Elias et al, 2005). It 
was assumed that  some of the BCG strains that have been used for vaccines lost the genes responsible for synthesizing 
proteins that stimulate protective antibody generation (Svenson et al, 2010). BCG vaccine limitations have urged many 
researchers to work on further vaccine improvement by proposing new vaccine candidates from recombinant proteins 
or recombinant strains.  
Several proteins of M. tuberculosis are required as a defense mechanism  inside host cells, particularly in the 
macrophages or as disease progression. Srivastava, et al. reported  that several genes that have been fused with gfp gene 
were expressed inside macrophage, such as Rv0619 (mce1A), Rv3097c(PE_PGRS63), Rv2232, Rv1026, Rv1635, viuB, 
Rv2231 (cobC), and Rv0997 gene. Mce1A gene showed the highest expression level whereas PE_PGRS63 gene was 
the lowest.  According to a function analysis,  mce1A gene was predicted to display a role in host invasion by M. 
tuberculosis and survival of the pathogen in the human macrophages, while PE_PGRS63 gene is probably a triacyl 
glycerol lipase (esterase) (Srivastava et al, 2007).  
Studies on protein expression of mce1A gene of Mycobacterium tuberculosis Beijing strain as local isolates 
have not been done much in Indonesia. Therefore, in this article we report cloning and expression of  mce1A gene of  
M.  tuberculosis Beijing strain as local isolate and standard strain H37Rv as a comparison on the expression system of 
Escherichia coli BL21(DE3). The results of this study are expected to open up opportunities for further research on the 
effects of the expressed protein to the immune system and to provide a possibility to develop TB subunit vaccine 
candidates. 
 
Materials and Methods 
Strain, plasmid and media 
 
M. tuberculosis Beijing strain was from the Laboratory of Bacteriology, Puslitbang Kemenkes RI while the 
M. tuberculosis H37Rv strain was from the Laboratory of Tuberculosis, Microbiology Department, University of 
Indonesia; E. coli DH5α and the plasmid pET-28a were purchased from Novagen, USA; E. coli BL-21(DE3) was from 
Promega,USA.  
The Beijing and H37Rv strains were grown on Lowenstein-Jensen agar at 37°C, while E.coli DH5α and 
BL21(DE3) cells were in Luria-Bertani (LB) broth or on LB agar in presence of kanamycin (30 µg/ml) wherever 
appropriate. 
 
M. tuberculosis Beijing strain and H37Rv mce1A gene synthesis and cloning into E. coli strain DH5α and 
BL21(DE3) 
 
Mce1A gene from H37Rv (Rv0619) and Beijing strains were each amplified by PCR technique using 
FastStart DNA Polymerase (Roche Applied Science, Germany). The DNA sequences of forward (F) and reverse (R) 
primers for the amplification of mce1A gene are shown below. 
mce1A F: 5’-GAATTCATGACGACGCCGGGG-3’ 
mce1A R: 5’-CTCGAGTCATGGGTTGATCGTG-3’ 
Forward primer contained an EcoRI restriction enzyme site (shown in bold) whereas the reverse primer contained a 
XhoI restriction site (shown in bold). The reaction mixtures in a final volume of 50 µl contained; M. tuberculosis 
genomic DNA, 5 µl of 10x polymerase buffer (Roche), 20 pmol of each primer and 100 µmol of dNTPs. The cycle 
parameters consisted of thirty five (35) cycle of 5 min at 95°C; 30 s at 95°C; 30 s at 55°C; 1 min 30 s at 72°C and 
finalized with 72°C for 7 min. The amplified products were resolved by agarose-gel electrophoresis. The PCR resulted 
in amplification of a single DNA product of the expected size, the gel slice was excised and the DNA fragment was 
purified. 
  Each resulting amplicons were subsequently inserted into the pET-28a (Novagen) plasmid inframe with the T7 
promoter and the T7 terminator region to generate the recombinant plasmids pET28a/Mce1Abeijing and 
pET28a/Mce1AH37Rv respectively with hexa histidine tags. To illustrate the schematic construction of plasmid is 
shown as reference in Fig.1. Finally, plasmids pET28a/Mce1ABeijing and pET28a/Mce1AH37Rv were transformed 
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into DH5α and BL21(DE3) strains of E. coli for expression studies. The presence of the inserts was confirmed by PCR 
colony, plasmid isolation and DNA sequencing. 
  
Kanamycin
ORI
F1 origin
His Tag
pET 28a
(5369 bp)
T7 promoter
Mce1A
terminator
 
 
 
 
 
Expression of recombinant Mce1A in E. coli BL21(DE3) 
 
 An overnight culture of E. coli BL21(DE3) carrying the recombinant expression plasmid pET28a/Mce1A-
Beijing was diluted 1:10 in fresh LB broth containing kanamycin and grown with vigourous shaking at 37°C to an 
optical density at 600 nm (OD600) of 0.4.  Isopropyl-ß-D-1-thiogalactopyranosida (IPTG, Sigma) was added to the 
culture to a final concentration of 1 mM and the induced cultures were grown for an additional 4 h. Cells were 
harvested by centrifugation at 5,000 rpm for 10 min at 4°C and the supernatant was discarded. The pellet was 
subsequently washed in sterile cold distilled water and then centrifuged at 5,000 rpm for 10 min at 4°C and the 
supernatant was discarded. The pellet was resuspended in sterile, cold distilled water and analysed on SDS-PAGE for 
expression of the recombinant protein. The expressed Mce1A protein was confirmed with a Western blot experiment 
using anti-Hisdetector
TM
 Nickel-HRP conjugate (KPL). The recombinant Mce1A-H37Rv was also expressed and 
confirmed using the same protocol. 
 
Results 
Analysis of Mce1A gene in the recombinant plasmids  
 
The presence of mce1A gene in each recombinant plasmid, i.e pET28a/Mce1ABeijing or 
pET28a/Mce1AH37Rv, was verified by using PCR colony technique using 5’vector primer and 3’insert primer and 
visualized using an agarose gel. The band of the resulting amplicon appeared on the gel as a single band at the size as it 
should be, suggesting that there is an insert of mce1A gene. Further analysis was performed by isolating the DNA 
plasmid and visualizing it in agarose 0,8%. The band of the recombinant plasmids were bigger in size than the wild type 
plasmid.  Analysis for orientation and framing of mce1A gene in each recombinant plasmid was performed with DNA 
sequencing. Based on these results, the mce1A genes were succesfully fused in the recombinant plasmids with T7 
promoter and T7 terminal region (data not shown). 
 
Expression of recombinant protein Mce1A in E. coli BL21(DE3) 
 
The expression of Mce1A from each recombinant plasmids was studied in E. coli BL21(DE3) strain. By 
detecting proteins using SDS-PAGE 15%, it appeared that both plasmids in this strain were able to express His-tagged 
Mce1A at high level. Interestingly, the molecular weight of the expressed proteins was higher than expected. They 
were observed at ~95 kDa (Figure 2) instead of 47 kDa as the calculated molecular weight for Mce1A. For further 
confirmation we detected the proteins using anti-His-tag monoclonal antibody by Western blot technique. The 
molecular weight of the proteins was are also higher than expected (Figure 3). 
 
 
 
 
 
 
 
Figure 1: Schematic construction of recombinant plasmid pET28a/Mce1A. The reading frame 
consist of: T7 promoter, Mce1A gene insert,  His-tag and T7 terminator. Kanamycin resistance 
gene as selection marker and Origin of Replication site (ORI).  
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Figure 2: SDS-polyacrylamide gel electrophoresis of whole-cell lysates of uninduced and induced recombinant E. coli 
BL21(DE3) cells. Lane M: markers; their molecular weight is indicated in kDa on the right side. Lane 1 and 2: lysate of 
E. coli BL21(DE3) cells carrying pET28a/Mce1A-Beijing with and without IPTG induction respectively; Lane 3 and 4: 
lysate of E. coli BL21(DE3) cells carrying pET28a/Mce1A-H37Rv with and without IPTG induction respectively; 
Lane 5: lysate of IPTG-induced E. coli BL21(DE3) containing wild type pET28a; Lane 6: lysate of IPTG-uninduced E. 
coli BL21(DE3) containing wild type pET28a. Expressed proteins are indicated by an arrow. 
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Figure 3: Western blot analysis. Proteins were separated by SDS-PAGE and electrotransferred to a nitrocellulose 
membrane. Monoclonal antibody against His-tag was used at a dilution of 1:8000 to detect signal of the recombinant 
proteins.  Lane M: protein markers; their molecular weight is indicated in kDa on the right side. Lane 1 and 2: lysate of 
E. coli BL21(DE3) cells carrying pET28a/Mce1A-Beijing with and without IPTG induction, respectively; Lane 3 and 
4: lysate of E. coli BL21(DE3) cells carrying pET28a/Mce1A-H37Rv with and without IPTG induction, respectively; 
Expressed proteins are indicated by an arrow. 
 
 
Discussion 
 
The initial step in the pathogenesis by intracellular pathogens is the invasion of the host cell. In case of M. 
tuberculosis, Mce1A protein of mce1 operon was the first protein of the pathogen to be implicated in its invasion and 
survival inside the macrophages (Ahmad et al 2004, Harboe et al 2002). Mammalian cell entry (Mce) proteins are a 
family of proteins that encodes invasin/adhesins-like proteins with hydrophobic amino acid regions at the N-terminus, 
possibly representing signal sequences. These proteins are located on the bacterial cell surface (Ahmad et al, 2005). 
Recombinant proteins can be expressed using prokaryotic systems, eukaryotic systems or in vitro systems. 
We chose the prokaryotic systems because we would like to express a protein of prokaryotic origin and the obvious 
choice is to use E. coli. The E. coli system is the first-choice host for the initial screening of recombinant protein 
expression, because these cells can be readily manipulated, are cultured inexpensively and grow rapidly. An E.coli 
expression vector possesses the same features found in any vector, such as a selection marker, origin of replication, 
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transcriptional promoter, 5’ untranslated region (5’UTR) and translation initiation site. The pET expression system 
featuring the T7 promoter is by far the most widely used system for heterogeneous expression in E. coli. (Jia B, Jeon 
CO, 2016). 
We also used E. coli strain BL21(DE3) as expression vector that allow high-efficiency protein expression of 
any gene that is under the control of a T7 promoter and has a ribosome binding site. It is lysogenic for λ-DE3, which 
contains the T7 bacteriophage gene I, encoding T7 RNA polymerase under the control of the lacUV promoter. T7 
promoter activity is strong, and a recombinant protein can accumulate to up to 50% of total cellular proteins. T7 
expression hosts such as DE3 strains contain a chromosomal copy of the T7 phage RNA polymerase gene under control 
of the lac promoter derivative lacUV5. When Isopropyl-ß-D-1-thiogalactopyranosida (IPTG) is added, LacI binding to 
the lac operator is inhibited, allowing for the expression of T7 polymerase, which transcribes the target gene and leads 
to recombinant protein production (Jia B, Jeon CO, 2016).  
In the present study we have generated recombinant Escherichia coli BL21(DE3) clones in which 
Mycobacterium tuberculosis Beijing and H37Rv strain Mce1A transgene are integrated. SDS-PAGE and Western blot 
analysis suggested that the molecular weight of the recombinant protein from both clones are about twice (~95 kDa) the 
calculated molecular weight for Mce1A from M. tuberculosis (47 kDa). Several explanations in regard to this 
observation may be considered. Mammalian cell entry (Mce) proteins are a family of proteins that encodes 
invasin/adhesins-like proteins with hydrophobic amino acid regions at the N-terminus, possibly representing signal 
sequences. These proteins are located on the bacterial cell surface (Ahmad et al, 2005). Generally, monomeric Mce1A 
was difficult to be obtained in a pure form as the protein showed the tendency to degrade and formed aggregates of 
different sizes. This resulted in the appearance of protein bands of lower or higher molecular weight than the 47 kDa 
protein band expected from monomeric Mce1A (Ahmad et al, 1999). Another study reported that in sonicates of M. 
tuberculosis, the Mce1A protein band was located at a high position on the gel, corresponding to the 250 kDa 
molecular mass marker. This position did not change in different experiments that used increased concentrations of 
SDS in the application buffer. These findings may indicate a type of complex formation between Mce1A and other 
component(s) via covalent bonds. Also, there is a tendency of free Mce1A to aggregate into higher molecular weight 
forms (Harboe et al, 1999). The amino acid identity exhibited by various Mce proteins of each mce operon is similar to 
that exhibited by other conserved proteins and indicates a common evolutionary origin from an ancestral mce gene. 
(Ahmad et al, 2005). Further study on Mce3 proteins encoded by the mce3 operon of M. tuberculosis also showed that 
these Mce3 proteins exhibited greater tendency to produce dimeric forms which persisted even under the reducing and 
denaturing conditions of SDS-PAGE (Ahmad et al, 2004). Another study on purified Mce1A protein detected the 
protein as doublet. Since anti His-tag antibodies detected the lower molecular weight band, it is probably due to partial 
degradation (Saini, 2008).    
 
Conclusion 
 
We successfully cloned and expressed mce1A (Rv0169) genes of M. tuberculosis mce1 operon from Beijing 
and H37Rv strains in E. coli. The recombinant protein molecular weight from both clones are about twice (~95 kDa) as 
the calculated for Mce1A from M. tuberculosis (47 kDa). We assumed that the recombinant protein is in their dimeric 
form or alternatively formed aggregates of different sizes. This explanation should be valuable in further studies of 
expression at the protein level and exposure of proteins on the cell surface of M. tuberculosis under different 
experimental conditions. 
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